Jason Hafron

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Astellas Pharma Inc
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Astellas Pharma Inc
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Amgen
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bayer
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Bayer
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Blue Earth Diagnostics
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Dendreon Pharmaceuticals LLC
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Dendreon Pharmaceuticals LLC
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Eli Lilly and Company
    Date added:
    09/20/2023
    Date updated:
    09/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Immunis.AI
    Date added:
    09/20/2023
    Date updated:
    09/20/2023

Pages

Return to 2023 Midwest Precision Oncology Symposium